ALIVUS LIFE SCIENCES LTD.

NSE : ALIVUSBSE : 543322ISIN CODE : INE03Q201024Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 147448.51 Face Value (Rs.) : 2 House : Glenmark
BSECurrent Price (Rs.) 1203.25Change (Rs.)44.05 (+3.8 %)
PREV CLOSE (Rs.) 1159.20
OPEN PRICE (Rs.) 1174.40
BID PRICE (QTY) 1202.00 (1)
OFFER PRICE (QTY) 1203.95 (67)
VOLUME 10016
TODAY'S LOW / HIGH (Rs.)1174.40 1223.60
52 WK LOW / HIGH (Rs.)830 1193.3
NSECurrent Price (Rs.) 1217.60Change (Rs.)57.6 (+4.97 %)
PREV CLOSE( Rs. ) 1160.00
OPEN PRICE (Rs.) 1182.80
BID PRICE (QTY) 1217.70 (110)
OFFER PRICE (QTY) 1218.00 (1)
VOLUME 120312
TODAY'S LOW / HIGH(Rs.) 1172.90 1225.00
52 WK LOW / HIGH (Rs.)819 1193.9

SMART QUOTES

STOCK SUMMARY

Trade Value (Rs. in Lacs)
120.52
Dividend Yield(%)
0.42
TTM EPS (Rs.)
49.12
P/E Ratio
24.45
Book Value (Rs.)
284.45
Face Value (Rs.)
2
MCap (Rs. in Mn)
147448.51
Price/Earning (TTM)
21.62
Price/Sales (TTM)
5.69
Price/Book (MRQ)
4.22
PAT Margin (%)
ROCE (%)

COMPANY INFO

Incorporation Year : 23-06 2011

Management Info :

Hiren K Patel - Chairman Yasir Rawjee - Managing Director

Registered Office :

Address : Plot No. 170-172,Chandramouli Industrial Estate,Mohol Bazarpeth,
Solapur,
Maharashtra-413213

Phone : 02189 234456/234246

Website : www.alivus.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

21Mar Alivus Life Sciences informs about di
Pursuant to regulation 30(2) of the Securities and Exchange Board of Ind..
16Feb Alivus Life Sciences informs about upd
Alivus Life Sciences has informed that on Saturday, February 14, 2026, a..
15Jan Alivus Life Sciences informs about ana
Alivus Life Sciences has informed that it enclosed details of Earnings C..

FINANCIALS

QTR Jun 26 ANNUAL 26
Net Profit1600.765644.83000000001
Gross Profit 2122.23 7513.09000000001
Operating Profit 2341.15 8576.95
Net Sales 6404.14 25518.32
Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

PEER GROUP

Neuland Laboratories (BSE)
 19760.90 (3.64%)
M.Cap (Rs. in Cr)25326.20
Divi's Laboratories (BSE)
 8433.25 (4.67%)
M.Cap (Rs. in Cr)223732.94
Astrazeneca Pharma (BSE)
 8290.85 (2.31%)
M.Cap (Rs. in Cr)20660.00
NGL Fine-Chem (BSE)
 3404.00 (4.26%)
M.Cap (Rs. in Cr)2112.39

SHAREHOLDING PATTERN

PROMOTERS
74.87%
NON-INSTITUTION
12.41%
MUTUAL FUNDS/UTI
5.65%
FI/BANKS/INSURANCE
0.27%
GOVERNMENT
0%
FII
0%